Related Experiment Video
Updated: Feb 28, 2026

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
Published on: June 18, 2021
A devastating case of diarrhea-associated hemolytic uremic syndrome associated with extensive cerebral infarction;
Werner Keenswijk1, Evelyn Dhont2, Ann Raes1
1a Department of Pediatrics, Pediatric Nephrology , Ghent University Hospital , Ghent , Belgium.
Insights
Diarrhea-associated hemolytic uremic syndrome (D+HUS) can cause severe kidney and neurological complications. While eculizumab showed some benefit, neurological damage in this pediatric case was irreversible, highlighting the need for better treatments.
Area of Science:
- Pediatric Nephrology
- Neurology
- Critical Care Medicine
Background:
- Diarrhea-associated hemolytic uremic syndrome (D+HUS) is a significant cause of acute kidney injury in children.
- Neurological involvement is common in D+HUS, though often reversible.
- Limited data exists on effective treatments for severe D+HUS, particularly for neurological complications.
Abstract:
A 4-year-old girl with diarrhea-associated hemolytic uremic syndrome (D+HUS) was transferred to the PICU of our center due to deteriorating renal function and neurological involvement. On admission, a comatous child was seen with hypoventilation and she was placed on mechanical ventilation. Hemodialysis was commenced but plasma exchange was discontinued due to repeated hypersensitivity reactions. A trial of eculizumab was given in light of the worsening of her neurologic condition with development of a pyramidal syndrome and deepening of the coma. Hematological and renal improvement were noted but severe neurologic involvement persisted. MRI revealed extensive bilateral zones of corticocerebral infarction and neurological damage proved to be irreversible. Diarrhea-associated hemolytic uremic syndrome is a common cause of Acute Kidney Injury associated with severe short- and long-term complications. Neurologic involvement is frequent but often reversible. Currently, no effective treatment strategies are available and a paucity of data exists concerning the efficacy of potential treatment options such as early plasma exchange, eculizumab, and high dose corticosteroids. A concerted effort is needed to early identify patients at risk for poor outcome with trials aimed at evaluating the efficacy of potential treatment options for this subgroup.
Related Concept Videos
Hemodialysis II: Procedure and Complications
Chronic Kidney Disease II: Clinical Manifestations
Hypersensitivity Reactions: Cytolytic Reactions
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury III: Clinical Manifestations

